2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Kaposi Disease in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Etoposide (VP16) is a topoisomerase II inhibitor and has been used for the treatment of non-small cell lung cancer (NSCLC)." | 5.48 | 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells. ( Chen, JC; Li, YT; Lin, MC; Lin, YC; Lin, YW; Ma, PF; Peng, YS; Wu, CH; Zheng, HY, 2018) |
| "Etoposide (VP16) is a topoisomerase II inhibitor and has been used for the treatment of non-small cell lung cancer (NSCLC)." | 1.48 | 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells. ( Chen, JC; Li, YT; Lin, MC; Lin, YC; Lin, YW; Ma, PF; Peng, YS; Wu, CH; Zheng, HY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC | 1 |
| Ma, PF | 1 |
| Lin, YC | 1 |
| Wu, CH | 1 |
| Peng, YS | 1 |
| Zheng, HY | 1 |
| Lin, MC | 1 |
| Li, YT | 1 |
| Lin, YW | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Kaposi Disease
| Article | Year |
|---|---|
17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells.
Topics: Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Down-Regulation; Drug | 2018 |